Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Patient, disease, and treatment characteristics of early-stage Hodgkin lymphoma patients treated with ABVD and RT (n = 174)
| Characteristic | Number |
|---|---|
| Median Age (Range), years | 31 (18–83) |
| Stage I / Stage II | 32 (18%) / 142 (82%) |
| B Symptoms | 53 (31%) |
| Bulk | 52 (30%) |
| Extranodal disease | 9 (5%) |
| Median Number of ABVD Cycles (Range) | 4 (2–6) |
| Median RT Dose (Range), Gy | 30.6 (20–42.2) |
ABVD = doxorubicin, bleomycin, vinblastine and dacarbazine
RT = radiation therapy
